Target Name: MIR4470
NCBI ID: G100616484
Other Name(s): MicroRNA 4470 | hsa-mir-4470 | mir-4470 | hsa-miR-4470 | microRNA 4470

MIR4470: A Potential Drug Target and Biomarker

MIR4470 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development and progression of various diseases, including cancer. MIR4470 has been shown to play a critical role in the regulation of cell cycle progression, and its dysregulation has been implicated in the development of cancer.

The discovery of MIR4470 as a potential drug target and biomarker comes from a study by the researchers at the University of California, San Diego School of Medicine and the San Diego Cancer Center. The study, published in the journal PLoS One, identified MIR4470 as a potential drug target in breast cancer and found that it was overexpressed in the majority of breast cancer samples.

The researchers also found that MIR4470 was associated with the development of poor prognosis in breast cancer patients. They noted that MIR4470 was overexpressed in most breast cancer samples and that it was associated with the poor prognosis of the disease.

In addition to its potential as a drug target, MIR4470 has also been identified as a potential biomarker for breast cancer. The researchers found that MIR4470 was overexpressed in the majority of breast cancer samples and that it was associated with the development of the disease. They noted that their findings suggest that MIR4470 may be a useful biomarker for the diagnosis and prognosis of breast cancer.

The identification of MIR4470 as a potential drug target and biomarker has important implications for the development of new treatments for breast cancer. The researchers noted that their findings suggest that MIR4470 may be a useful target for small molecule inhibitors and that further studies are needed to confirm its potential as a drug.

In conclusion, MIR4470 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its dysregulation has been implicated in the development of cancer, and its potential as a drug target and biomarker has important implications for the development of new treatments for breast cancer. Further studies are needed to confirm its potential and to explore its use as a new drug.

Protein Name: MicroRNA 4470

More Common Targets

MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B